Intrinsiqq
Humana Inc. logo

Humana Inc. Quality Score

HUM

⊜ Compare
Quality45

Valuation is the primary weakness (avg 40/100). No single area scores well.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
40/100
44.6x

Above 30x, priced for sustained outperformance

Cash Flow Multiple
40/100
39.4x

Above 30x, cash flow yield is thin

Revenue Growth
100/100
10.2%

Above 10% CAGR, strong compounder

Cash Flow Growth
0/100
-22.1%

Below 2%, essentially flat

Business Quality & Capital Allocation

Share Dilution
100/100
-5.1%

Shrinking >2%, active buybacks

Margin Trend
0/100
-2.3pp

Contracted >2pp, margin pressure

Capital Structure
100/100
-$7.97B

Net cash position, no leverage concern

2022
$18.9B
$11.7B
2023
$21.3B
$12.3B
2024
$20.4B
$12.2B
2025
$19.9B
$12.9B
TTM
$22.0B
$14.0B
CashDebt
Return on Capital
0/100
7.1%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Humana (HUM) quality: score, margins and returns

Humana (HUM) scores 45/100 on Intrinsiqq's quality score (a mixed business), a weighted blend of 8 metrics each scored 0 to 100, on 1.8% operating margins and 7.1% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Humana (HUM) a high-quality business?+

Humana scores 45 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a mixed business on these measures. Recent figures include a 1.8% operating margin and a 7.1% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Humana's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from HUM's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Humana scores well and where it falls behind.

What is Humana's return on invested capital (ROIC)?+

Humana earns about 7.1% on its invested capital, which is modest. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to HUM's margins and growth on this scorecard to judge durability.

How profitable is Humana?+

Humana runs an operating margin of about 1.8% and a net margin of about 0.8%. Revenue has grown at roughly 10.9% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 29 Apr 2026, covering the period ending 31 Mar 2026, as reported to the SEC. Data last refreshed 3 Oct 2026. How this is calculated.

Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Hospital & Medical Service Plans · Pick stocks to compare with HUM

CompareIntrinsic value
ELVElevance Health, Inc.
$434.18+4.94%53
CNCCentene Corporation
$76.01+12.64%55
MOHMolina Healthcare Inc.
$226.49+8.97%37
OSCROscar Health, Inc.
$35.19+8.58%88
CIThe Cigna Group
$303.10+2.59%43
UNHUnitedHealth Group Incorporated
$409.38+1.22%48
AFLAflac Inc.
$125.85+1.46%81
PFGPrincipal Financial Group, Inc.
$117.31+4.13%59

Held by ETFs

HUM is in 279 US ETFs. The largest of them, with HUM's weight in each:

Spot a number that looks wrong? Check it in HUM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HUM

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.